Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Regulation of eIF4F Translation Initiation Complex by the Peptidyl Prolyl Isomerase FKBP7 in Taxane-resistant Prostate Cancer.

Garrido MF, Martin NJ, Bertrand M, Gaudin C, Commo F, El Kalaany N, Al Nakouzi N, Fazli L, Del Nery E, Camonis J, Perez F, Lerondel S, Le Pape A, Compagno D, Gleave M, Loriot Y, Désaubry L, Vagner S, Fizazi K, Chauchereau A.

Clin Cancer Res. 2019 Jan 15;25(2):710-723. doi: 10.1158/1078-0432.CCR-18-0704. Epub 2018 Oct 15.

PMID:
30322877
2.

Endogenous Galectin-1 in T Lymphocytes Regulates Anti-prostate Cancer Immunity.

Corapi E, Carrizo G, Compagno D, Laderach D.

Front Immunol. 2018 Sep 26;9:2190. doi: 10.3389/fimmu.2018.02190. eCollection 2018.

3.

Process models of interrelated speech intentions from online health-related conversations.

Epure EV, Compagno D, Salinesi C, Deneckere R, Bajec M, Žitnik S.

Artif Intell Med. 2018 Sep;91:23-38. doi: 10.1016/j.artmed.2018.06.007. Epub 2018 Jul 18.

PMID:
30030089
4.

Stable and high expression of Galectin-8 tightly controls metastatic progression of prostate cancer.

Gentilini LD, Jaworski FM, Tiraboschi C, Pérez IG, Kotler ML, Chauchereau A, Laderach DJ, Compagno D.

Oncotarget. 2017 Jul 4;8(27):44654-44668. doi: 10.18632/oncotarget.17963.

5.

In Vivo Hemin Conditioning Targets the Vascular and Immunologic Compartments and Restrains Prostate Tumor Development.

Jaworski FM, Gentilini LD, Gueron G, Meiss RP, Ortiz EG, Berguer PM, Ahmed A, Navone N, Rabinovich GA, Compagno D, Laderach DJ, Vazquez ES.

Clin Cancer Res. 2017 Sep 1;23(17):5135-5148. doi: 10.1158/1078-0432.CCR-17-0112. Epub 2017 May 16.

6.

Galectin-1 triggers epithelial-mesenchymal transition in human hepatocellular carcinoma cells.

Bacigalupo ML, Manzi M, Espelt MV, Gentilini LD, Compagno D, Laderach DJ, Wolfenstein-Todel C, Rabinovich GA, Troncoso MF.

J Cell Physiol. 2015 Jun;230(6):1298-309. doi: 10.1002/jcp.24865.

PMID:
25469885
7.

Regulation of galectins by hypoxia and their relevance in angiogenesis: strategies and methods.

Salatino M, Croci DO, Laderach DJ, Compagno D, Gentilini L, Dalotto-Moreno T, Dergan-Dylon LS, Méndez-Huergo SP, Toscano MA, Cerliani JP, Rabinovich GA.

Methods Mol Biol. 2015;1207:293-304. doi: 10.1007/978-1-4939-1396-1_19.

PMID:
25253148
8.

Study of galectins in tumor immunity: strategies and methods.

Cerliani JP, Dalotto-Moreno T, Compagno D, Dergan-Dylon LS, Laderach DJ, Gentilini L, Croci DO, Méndez-Huergo SP, Toscano MA, Salatino M, Rabinovich GA.

Methods Mol Biol. 2015;1207:249-68. doi: 10.1007/978-1-4939-1396-1_16.

PMID:
25253145
9.

Glycans and galectins in prostate cancer biology, angiogenesis and metastasis.

Compagno D, Gentilini LD, Jaworski FM, Pérez IG, Contrufo G, Laderach DJ.

Glycobiology. 2014 Oct;24(10):899-906. doi: 10.1093/glycob/cwu055. Epub 2014 Jun 16.

PMID:
24939371
10.

Galectin-8: a matricellular lectin with key roles in angiogenesis.

Troncoso MF, Ferragut F, Bacigalupo ML, Cárdenas Delgado VM, Nugnes LG, Gentilini L, Laderach D, Wolfenstein-Todel C, Compagno D, Rabinovich GA, Elola MT.

Glycobiology. 2014 Oct;24(10):907-14. doi: 10.1093/glycob/cwu054. Epub 2014 Jun 16. Review.

PMID:
24939370
11.

Galectins: major signaling modulators inside and outside the cell.

Compagno D, Jaworski FM, Gentilini L, Contrufo G, González Pérez I, Elola MT, Pregi N, Rabinovich GA, Laderach DJ.

Curr Mol Med. 2014;14(5):630-51. Review.

PMID:
24894174
12.

Expression, localization and function of galectin-8, a tandem-repeat lectin, in human tumors.

Elola MT, Ferragut F, Cárdenas Delgado VM, Nugnes LG, Gentilini L, Laderach D, Troncoso MF, Compagno D, Wolfenstein-Todel C, Rabinovich GA.

Histol Histopathol. 2014 Sep;29(9):1093-105. doi: 10.14670/HH-29.1093. Epub 2014 Mar 31. Review.

PMID:
24696431
13.

Galectins as new prognostic markers and potential therapeutic targets for advanced prostate cancers.

Laderach DJ, Gentilini L, Jaworski FM, Compagno D.

Prostate Cancer. 2013;2013:519436. doi: 10.1155/2013/519436. Epub 2013 Sep 24. Review.

14.

Delineating the "galectin signature" of the tumor microenvironment.

Compagno D, Laderach DJ, Gentilini L, Jaworski FM, Rabinovich GA.

Oncoimmunology. 2013 Apr 1;2(4):e23565.

15.

A unique galectin signature in human prostate cancer progression suggests galectin-1 as a key target for treatment of advanced disease.

Laderach DJ, Gentilini LD, Giribaldi L, Delgado VC, Nugnes L, Croci DO, Al Nakouzi N, Sacca P, Casas G, Mazza O, Shipp MA, Vazquez E, Chauchereau A, Kutok JL, Rodig SJ, Elola MT, Compagno D, Rabinovich GA.

Cancer Res. 2013 Jan 1;73(1):86-96. doi: 10.1158/0008-5472.CAN-12-1260. Epub 2012 Oct 29.

16.

TSLP1: a new piece in the puzzle of tumor-associated Th2-type inflammation.

Laderach DJ, Pesoa SA, Compagno D, Rabinovich GA.

Immunotherapy. 2011 Jun;3(6):713-7. doi: 10.2217/imt.11.67. No abstract available.

PMID:
21668306
17.

Stemness markers characterize IGR-CaP1, a new cell line derived from primary epithelial prostate cancer.

Chauchereau A, Al Nakouzi N, Gaudin C, Le Moulec S, Compagno D, Auger N, Bénard J, Opolon P, Rozet F, Validire P, Fromont G, Fizazi K.

Exp Cell Res. 2011 Feb 1;317(3):262-75. doi: 10.1016/j.yexcr.2010.10.012. Epub 2010 Oct 23.

PMID:
20974126
18.

Modulation of endothelial cell migration and angiogenesis: a novel function for the "tandem-repeat" lectin galectin-8.

Delgado VM, Nugnes LG, Colombo LL, Troncoso MF, Fernández MM, Malchiodi EL, Frahm I, Croci DO, Compagno D, Rabinovich GA, Wolfenstein-Todel C, Elola MT.

FASEB J. 2011 Jan;25(1):242-54. doi: 10.1096/fj.09-144907. Epub 2010 Sep 27.

PMID:
20876211
19.

Dissecting the signal transduction pathways triggered by galectin-glycan interactions in physiological and pathological settings.

Laderach DJ, Compagno D, Toscano MA, Croci DO, Dergan-Dylon S, Salatino M, Rabinovich GA.

IUBMB Life. 2010 Jan;62(1):1-13. doi: 10.1002/iub.281. Review.

20.

Dok-4 is a novel negative regulator of T cell activation.

Gérard A, Ghiotto M, Fos C, Guittard G, Compagno D, Galy A, Lemay S, Olive D, Nunès JA.

J Immunol. 2009 Jun 15;182(12):7681-9. doi: 10.4049/jimmunol.0802203.

21.

SIRNA-directed in vivo silencing of androgen receptor inhibits the growth of castration-resistant prostate carcinomas.

Compagno D, Merle C, Morin A, Gilbert C, Mathieu JR, Bozec A, Mauduit C, Benahmed M, Cabon F.

PLoS One. 2007 Oct 10;2(10):e1006.

22.

A partial down-regulation of WASP is sufficient to inhibit podosome formation in dendritic cells.

Olivier A, Jeanson-Leh L, Bouma G, Compagno D, Blondeau J, Seye K, Charrier S, Burns S, Thrasher AJ, Danos O, Vainchenker W, Galy A.

Mol Ther. 2006 Apr;13(4):729-37. Epub 2005 Dec 15.

23.

RGS16 is a negative regulator of SDF-1-CXCR4 signaling in megakaryocytes.

Berthebaud M, Rivière C, Jarrier P, Foudi A, Zhang Y, Compagno D, Galy A, Vainchenker W, Louache F.

Blood. 2005 Nov 1;106(9):2962-8. Epub 2005 Jul 5.

PMID:
15998835
24.

RNA interference shows critical requirement for NF-kappa B p50 in the production of IL-12 by human dendritic cells.

Laderach D, Compagno D, Danos O, Vainchenker W, Galy A.

J Immunol. 2003 Aug 15;171(4):1750-7.

25.

Antisense effects of oligonucleotides complementary to the hairpin of the Leishmania mini-exon RNA.

Compagno D, Toulmé JJ.

Nucleosides Nucleotides. 1999 Jun-Jul;18(6-7):1701-4.

PMID:
10474250
26.

Antisense oligonucleotides containing modified bases inhibit in vitro translation of Leishmania amazonensis mRNAs by invading the mini-exon hairpin.

Compagno D, Lampe JN, Bourget C, Kutyavin IV, Yurchenko L, Lukhtanov EA, Gorn VV, Gamper HB Jr, Toulmé JJ.

J Biol Chem. 1999 Mar 19;274(12):8191-8.

27.

Control of gene expression in viruses and protozoan parasites by antisense oligonucleotides.

Toulmé JJ, Bourget C, Compagno D, Yurchenko L.

Parasitology. 1997;114 Suppl:S45-59. Review.

PMID:
9309768

Supplemental Content

Loading ...
Support Center